Edward Havranek
Concepts (459)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 50 | 2018 | 1963 | 2.480 |
Why?
| Hypertension | 20 | 2022 | 1065 | 2.460 |
Why?
| Antihypertensive Agents | 9 | 2021 | 432 | 2.020 |
Why?
| Medication Adherence | 10 | 2022 | 537 | 1.810 |
Why?
| Text Messaging | 5 | 2020 | 154 | 1.770 |
Why?
| Healthcare Disparities | 8 | 2023 | 487 | 1.610 |
Why?
| Socioeconomic Factors | 11 | 2021 | 1088 | 1.300 |
Why?
| Heart Diseases | 3 | 2019 | 332 | 1.220 |
Why?
| Social Values | 2 | 2021 | 36 | 1.200 |
Why?
| Racism | 3 | 2021 | 101 | 1.160 |
Why?
| Health Status | 12 | 2018 | 727 | 1.100 |
Why?
| Myocardial Infarction | 17 | 2015 | 932 | 1.020 |
Why?
| Blood Pressure | 9 | 2016 | 1537 | 1.010 |
Why?
| Weight Loss | 5 | 2018 | 633 | 0.990 |
Why?
| Social Determinants of Health | 2 | 2018 | 137 | 0.980 |
Why?
| Cardiovascular Diseases | 11 | 2019 | 1724 | 0.960 |
Why?
| Hospitalization | 24 | 2020 | 1764 | 0.950 |
Why?
| Out-of-Hospital Cardiac Arrest | 3 | 2019 | 78 | 0.920 |
Why?
| Prediabetic State | 2 | 2016 | 225 | 0.880 |
Why?
| Patient Satisfaction | 6 | 2019 | 585 | 0.860 |
Why?
| Health Services Accessibility | 2 | 2019 | 771 | 0.850 |
Why?
| Aged | 79 | 2021 | 19292 | 0.830 |
Why?
| Hypertrophy, Left Ventricular | 3 | 2008 | 103 | 0.820 |
Why?
| Resuscitation Orders | 2 | 2020 | 45 | 0.810 |
Why?
| Attitude to Health | 2 | 2021 | 409 | 0.810 |
Why?
| Sexual Health | 2 | 2020 | 47 | 0.800 |
Why?
| Humans | 141 | 2023 | 115859 | 0.790 |
Why?
| Middle Aged | 60 | 2022 | 27078 | 0.780 |
Why?
| Physician-Patient Relations | 5 | 2013 | 467 | 0.770 |
Why?
| Sexually Transmitted Diseases | 2 | 2020 | 154 | 0.750 |
Why?
| Health Status Disparities | 3 | 2021 | 207 | 0.740 |
Why?
| Male | 99 | 2022 | 56103 | 0.740 |
Why?
| Female | 102 | 2022 | 60070 | 0.730 |
Why?
| Depression | 8 | 2018 | 1145 | 0.720 |
Why?
| Residence Characteristics | 3 | 2021 | 275 | 0.690 |
Why?
| Primary Health Care | 4 | 2019 | 1520 | 0.670 |
Why?
| Cardiac Output, Low | 5 | 2006 | 64 | 0.670 |
Why?
| Atherosclerosis | 2 | 2019 | 341 | 0.630 |
Why?
| Diabetes Mellitus | 9 | 2018 | 905 | 0.630 |
Why?
| United States | 44 | 2023 | 12319 | 0.620 |
Why?
| Colorado | 22 | 2021 | 4122 | 0.620 |
Why?
| Choice Behavior | 1 | 2019 | 159 | 0.610 |
Why?
| Minority Groups | 3 | 2023 | 232 | 0.580 |
Why?
| Heart Arrest | 2 | 2020 | 289 | 0.550 |
Why?
| Communication | 4 | 2023 | 749 | 0.550 |
Why?
| American Heart Association | 3 | 2018 | 266 | 0.520 |
Why?
| Safety-net Providers | 2 | 2018 | 95 | 0.520 |
Why?
| Emergency Service, Hospital | 5 | 2021 | 1842 | 0.510 |
Why?
| Health Services Research | 2 | 2015 | 377 | 0.480 |
Why?
| Delivery of Health Care | 7 | 2023 | 847 | 0.460 |
Why?
| Risk Factors | 26 | 2019 | 8715 | 0.450 |
Why?
| Emergency Medical Services | 4 | 2023 | 591 | 0.450 |
Why?
| Aged, 80 and over | 29 | 2021 | 6434 | 0.450 |
Why?
| Blood Pressure Determination | 1 | 2014 | 123 | 0.440 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 682 | 0.430 |
Why?
| Adult | 30 | 2023 | 30814 | 0.410 |
Why?
| Guideline Adherence | 6 | 2021 | 497 | 0.410 |
Why?
| Medically Uninsured | 1 | 2013 | 122 | 0.410 |
Why?
| Decision Making | 2 | 2016 | 790 | 0.410 |
Why?
| Surveys and Questionnaires | 10 | 2018 | 4673 | 0.390 |
Why?
| Patient-Centered Care | 2 | 2016 | 477 | 0.390 |
Why?
| Decision Support Techniques | 1 | 2015 | 353 | 0.390 |
Why?
| Blood Pressure Monitoring, Ambulatory | 2 | 2011 | 61 | 0.390 |
Why?
| Kidney Diseases | 3 | 2011 | 355 | 0.390 |
Why?
| Physicians, Primary Care | 2 | 2018 | 222 | 0.380 |
Why?
| Cohort Studies | 26 | 2020 | 4960 | 0.380 |
Why?
| Follow-Up Studies | 17 | 2022 | 4443 | 0.380 |
Why?
| Survival Analysis | 7 | 2010 | 1218 | 0.370 |
Why?
| Carotid Artery Diseases | 1 | 2011 | 58 | 0.370 |
Why?
| Electrocardiography | 4 | 2009 | 560 | 0.370 |
Why?
| Ventricular Dysfunction, Left | 6 | 2008 | 366 | 0.370 |
Why?
| Insurance, Health | 1 | 2013 | 247 | 0.370 |
Why?
| Risk Assessment | 10 | 2019 | 2992 | 0.370 |
Why?
| Practice Patterns, Physicians' | 3 | 2018 | 1182 | 0.370 |
Why?
| Coronary Artery Disease | 3 | 2013 | 613 | 0.360 |
Why?
| Survival Rate | 13 | 2020 | 1649 | 0.330 |
Why?
| Exercise | 2 | 2018 | 1611 | 0.330 |
Why?
| Quality of Health Care | 7 | 2007 | 577 | 0.330 |
Why?
| Quality of Life | 12 | 2019 | 2390 | 0.320 |
Why?
| Cardiopulmonary Resuscitation | 3 | 2020 | 220 | 0.310 |
Why?
| Attitude to Death | 1 | 2008 | 60 | 0.310 |
Why?
| Heart Rate | 2 | 2011 | 700 | 0.300 |
Why?
| Proportional Hazards Models | 11 | 2015 | 1088 | 0.300 |
Why?
| Renin-Angiotensin System | 1 | 2008 | 72 | 0.300 |
Why?
| Patient Education as Topic | 4 | 2018 | 685 | 0.300 |
Why?
| Atrial Fibrillation | 2 | 2009 | 325 | 0.300 |
Why?
| Medicare | 14 | 2017 | 666 | 0.300 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 8 | 2008 | 180 | 0.290 |
Why?
| Retrospective Studies | 30 | 2020 | 12615 | 0.290 |
Why?
| Stroke | 3 | 2021 | 1016 | 0.280 |
Why?
| Sex Factors | 10 | 2020 | 1741 | 0.280 |
Why?
| Diabetic Angiopathies | 4 | 2009 | 244 | 0.270 |
Why?
| Kidney | 3 | 2011 | 1210 | 0.270 |
Why?
| Models, Statistical | 2 | 2013 | 612 | 0.270 |
Why?
| Cross-Sectional Studies | 14 | 2017 | 4447 | 0.260 |
Why?
| Prevalence | 7 | 2018 | 2270 | 0.260 |
Why?
| Value of Life | 1 | 2005 | 19 | 0.250 |
Why?
| Young Adult | 9 | 2021 | 10508 | 0.250 |
Why?
| Insurance, Health, Reimbursement | 2 | 2017 | 88 | 0.240 |
Why?
| Multivariate Analysis | 10 | 2017 | 1443 | 0.240 |
Why?
| Palliative Care | 4 | 2016 | 642 | 0.240 |
Why?
| Prognosis | 9 | 2018 | 3344 | 0.240 |
Why?
| Ambulances | 2 | 2023 | 50 | 0.240 |
Why?
| Monitoring, Ambulatory | 1 | 2005 | 82 | 0.240 |
Why?
| Patient Compliance | 4 | 2018 | 524 | 0.240 |
Why?
| Peer Review, Research | 1 | 2004 | 34 | 0.230 |
Why?
| Epidemiologic Studies | 1 | 2004 | 58 | 0.230 |
Why?
| Attitude of Health Personnel | 2 | 2012 | 991 | 0.220 |
Why?
| Single-Blind Method | 2 | 2021 | 256 | 0.220 |
Why?
| Nisoldipine | 1 | 2003 | 6 | 0.220 |
Why?
| Enalapril | 1 | 2003 | 16 | 0.220 |
Why?
| Treatment Outcome | 15 | 2023 | 9163 | 0.220 |
Why?
| Smoking Cessation | 1 | 2007 | 378 | 0.220 |
Why?
| Hypoglycemic Agents | 5 | 2012 | 1008 | 0.220 |
Why?
| Shock, Traumatic | 1 | 2023 | 16 | 0.220 |
Why?
| Pneumonia | 2 | 2019 | 576 | 0.220 |
Why?
| Social Class | 2 | 2019 | 210 | 0.220 |
Why?
| Sepsis | 2 | 2019 | 521 | 0.210 |
Why?
| Sexual Behavior | 3 | 2020 | 440 | 0.210 |
Why?
| Prospective Studies | 12 | 2019 | 6276 | 0.210 |
Why?
| Critical Illness | 2 | 2023 | 648 | 0.210 |
Why?
| Mexican Americans | 2 | 2015 | 101 | 0.200 |
Why?
| Delivery of Health Care, Integrated | 1 | 2005 | 231 | 0.200 |
Why?
| Communication Barriers | 1 | 2023 | 90 | 0.200 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2017 | 2090 | 0.200 |
Why?
| Perception | 1 | 2004 | 316 | 0.200 |
Why?
| Intention to Treat Analysis | 1 | 2021 | 69 | 0.200 |
Why?
| Glomerular Filtration Rate | 5 | 2011 | 605 | 0.190 |
Why?
| Telemedicine | 2 | 2011 | 667 | 0.190 |
Why?
| Electronic Health Records | 2 | 2018 | 805 | 0.190 |
Why?
| Acculturation | 2 | 2012 | 52 | 0.190 |
Why?
| Stroke Volume | 7 | 2008 | 510 | 0.190 |
Why?
| Cardiologists | 2 | 2018 | 41 | 0.190 |
Why?
| Drug Prescriptions | 6 | 2009 | 241 | 0.180 |
Why?
| Adolescent | 10 | 2020 | 17935 | 0.180 |
Why?
| Brain Ischemia | 2 | 2021 | 298 | 0.180 |
Why?
| Writing | 1 | 2021 | 85 | 0.180 |
Why?
| Professional-Patient Relations | 1 | 2021 | 143 | 0.180 |
Why?
| Incidence | 6 | 2021 | 2336 | 0.180 |
Why?
| Age Factors | 11 | 2018 | 2911 | 0.180 |
Why?
| Chronic Disease | 6 | 2018 | 1598 | 0.170 |
Why?
| Chi-Square Distribution | 5 | 2015 | 501 | 0.170 |
Why?
| Cardiology | 3 | 2007 | 260 | 0.170 |
Why?
| Time Factors | 10 | 2015 | 6182 | 0.160 |
Why?
| Quality Assurance, Health Care | 6 | 2007 | 315 | 0.160 |
Why?
| Fluid Therapy | 1 | 2020 | 122 | 0.160 |
Why?
| Health Care Surveys | 4 | 2019 | 540 | 0.160 |
Why?
| Shock | 1 | 2020 | 76 | 0.160 |
Why?
| Income | 1 | 2019 | 170 | 0.160 |
Why?
| Qualitative Research | 3 | 2019 | 966 | 0.160 |
Why?
| Public Opinion | 1 | 2019 | 59 | 0.160 |
Why?
| Formative Feedback | 1 | 2018 | 23 | 0.160 |
Why?
| Patient Selection | 5 | 2009 | 655 | 0.160 |
Why?
| Patient Care Team | 2 | 2018 | 522 | 0.160 |
Why?
| Medical Audit | 1 | 2018 | 75 | 0.160 |
Why?
| Emergency Treatment | 1 | 2019 | 115 | 0.160 |
Why?
| Severity of Illness Index | 3 | 2019 | 2590 | 0.160 |
Why?
| Patient Readmission | 5 | 2012 | 609 | 0.150 |
Why?
| Withholding Treatment | 2 | 2016 | 69 | 0.150 |
Why?
| Contraception | 1 | 2019 | 118 | 0.150 |
Why?
| Censuses | 1 | 2017 | 18 | 0.150 |
Why?
| Health Literacy | 2 | 2018 | 166 | 0.150 |
Why?
| Multilevel Analysis | 1 | 2017 | 26 | 0.150 |
Why?
| California | 1 | 2019 | 368 | 0.150 |
Why?
| Patient Navigation | 1 | 2019 | 64 | 0.150 |
Why?
| Angina Pectoris | 2 | 2008 | 62 | 0.150 |
Why?
| Odds Ratio | 6 | 2018 | 968 | 0.150 |
Why?
| Hyperglycemia | 3 | 2010 | 295 | 0.150 |
Why?
| Peer Group | 1 | 2019 | 207 | 0.150 |
Why?
| International Cooperation | 1 | 2018 | 175 | 0.150 |
Why?
| Interviews as Topic | 3 | 2015 | 595 | 0.150 |
Why?
| Goals | 1 | 2018 | 159 | 0.140 |
Why?
| Comorbidity | 9 | 2012 | 1476 | 0.140 |
Why?
| ST Elevation Myocardial Infarction | 1 | 2017 | 51 | 0.140 |
Why?
| Statistics as Topic | 3 | 2008 | 299 | 0.140 |
Why?
| Logistic Models | 9 | 2017 | 1863 | 0.140 |
Why?
| Program Development | 1 | 2018 | 350 | 0.140 |
Why?
| Leadership | 2 | 2018 | 303 | 0.140 |
Why?
| Self-Management | 1 | 2018 | 126 | 0.130 |
Why?
| Urban Population | 1 | 2018 | 405 | 0.130 |
Why?
| Hospital Mortality | 5 | 2019 | 779 | 0.130 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 1193 | 0.130 |
Why?
| Weight Reduction Programs | 1 | 2017 | 91 | 0.130 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 65 | 0.130 |
Why?
| Registries | 6 | 2020 | 1772 | 0.130 |
Why?
| Organizational Case Studies | 1 | 2015 | 72 | 0.130 |
Why?
| Diuretics | 3 | 2006 | 67 | 0.130 |
Why?
| Cell Phone | 1 | 2016 | 78 | 0.130 |
Why?
| Predictive Value of Tests | 4 | 2010 | 1813 | 0.130 |
Why?
| Xanthines | 2 | 2007 | 15 | 0.130 |
Why?
| Renal Dialysis | 1 | 2019 | 371 | 0.130 |
Why?
| Diffusion of Innovation | 1 | 2015 | 95 | 0.130 |
Why?
| Clinical Decision-Making | 1 | 2017 | 273 | 0.120 |
Why?
| Education, Medical | 1 | 2018 | 225 | 0.120 |
Why?
| Exercise Test | 1 | 2017 | 541 | 0.120 |
Why?
| Thiazolidinediones | 3 | 2005 | 143 | 0.120 |
Why?
| Hypercholesterolemia | 1 | 2015 | 92 | 0.120 |
Why?
| Community Health Services | 2 | 2008 | 212 | 0.120 |
Why?
| Organizational Innovation | 1 | 2015 | 132 | 0.120 |
Why?
| Organizational Culture | 1 | 2015 | 121 | 0.120 |
Why?
| Lipoproteins | 1 | 2015 | 162 | 0.120 |
Why?
| Cultural Competency | 2 | 2013 | 73 | 0.120 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 125 | 0.120 |
Why?
| Blood Vessels | 1 | 2016 | 181 | 0.120 |
Why?
| Acute Coronary Syndrome | 1 | 2017 | 254 | 0.120 |
Why?
| ROC Curve | 2 | 2020 | 451 | 0.120 |
Why?
| Adiponectin | 1 | 2015 | 213 | 0.120 |
Why?
| Practice Guidelines as Topic | 4 | 2017 | 1405 | 0.120 |
Why?
| Pilot Projects | 3 | 2015 | 1379 | 0.120 |
Why?
| Ventricular Function, Left | 4 | 2009 | 469 | 0.120 |
Why?
| Cholesterol | 1 | 2015 | 368 | 0.110 |
Why?
| Aspirin | 3 | 2005 | 326 | 0.110 |
Why?
| Creatinine | 5 | 2006 | 431 | 0.110 |
Why?
| Kidney Failure, Chronic | 1 | 2019 | 491 | 0.110 |
Why?
| Triglycerides | 1 | 2015 | 471 | 0.110 |
Why?
| Disease Management | 3 | 2008 | 563 | 0.110 |
Why?
| Inpatients | 5 | 2009 | 380 | 0.110 |
Why?
| Metformin | 3 | 2005 | 278 | 0.100 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2005 | 1217 | 0.100 |
Why?
| Diabetes Complications | 3 | 2009 | 212 | 0.100 |
Why?
| Kaplan-Meier Estimate | 2 | 2015 | 816 | 0.100 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 373 | 0.100 |
Why?
| Hyperlipidemias | 1 | 2012 | 123 | 0.100 |
Why?
| Trust | 1 | 2012 | 108 | 0.100 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1725 | 0.100 |
Why?
| Adiposity | 1 | 2015 | 468 | 0.090 |
Why?
| Biomedical Research | 2 | 2007 | 589 | 0.090 |
Why?
| Pregnancy | 2 | 2020 | 5555 | 0.090 |
Why?
| Hospitals, Military | 1 | 2011 | 33 | 0.090 |
Why?
| Medical Laboratory Science | 1 | 2010 | 7 | 0.090 |
Why?
| Vascular Stiffness | 1 | 2015 | 411 | 0.090 |
Why?
| Diet | 2 | 2015 | 1074 | 0.090 |
Why?
| Health Promotion | 1 | 2017 | 690 | 0.090 |
Why?
| Adrenergic beta-Antagonists | 3 | 2008 | 293 | 0.090 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 129 | 0.090 |
Why?
| Affect | 1 | 2012 | 244 | 0.090 |
Why?
| Body Mass Index | 2 | 2016 | 1974 | 0.090 |
Why?
| Telephone | 1 | 2011 | 153 | 0.090 |
Why?
| Double-Blind Method | 4 | 2015 | 1664 | 0.090 |
Why?
| Health Status Indicators | 3 | 2008 | 155 | 0.090 |
Why?
| Nutrition Surveys | 2 | 2008 | 225 | 0.080 |
Why?
| Obesity | 2 | 2015 | 2523 | 0.080 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2009 | 146 | 0.080 |
Why?
| Infant, Newborn | 1 | 2019 | 5084 | 0.080 |
Why?
| Pharmacists | 1 | 2011 | 237 | 0.080 |
Why?
| Captopril | 1 | 2008 | 11 | 0.080 |
Why?
| Longitudinal Studies | 3 | 2011 | 2416 | 0.080 |
Why?
| Valsartan | 1 | 2008 | 22 | 0.080 |
Why?
| Tetrazoles | 1 | 2008 | 32 | 0.080 |
Why?
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 29 | 0.080 |
Why?
| Spirituality | 1 | 2009 | 69 | 0.080 |
Why?
| Spironolactone | 2 | 2005 | 33 | 0.080 |
Why?
| Health Surveys | 1 | 2010 | 447 | 0.080 |
Why?
| Spouse Abuse | 1 | 2008 | 43 | 0.080 |
Why?
| Valine | 1 | 2008 | 74 | 0.080 |
Why?
| Carbazoles | 1 | 2008 | 80 | 0.080 |
Why?
| Adenosine A1 Receptor Antagonists | 1 | 2007 | 2 | 0.080 |
Why?
| Linear Models | 4 | 2015 | 777 | 0.080 |
Why?
| Patients | 1 | 2009 | 164 | 0.070 |
Why?
| Propanolamines | 1 | 2008 | 94 | 0.070 |
Why?
| Medical Records Systems, Computerized | 1 | 2008 | 90 | 0.070 |
Why?
| Medically Underserved Area | 1 | 2008 | 80 | 0.070 |
Why?
| Insulin Resistance | 1 | 2015 | 1078 | 0.070 |
Why?
| United States Department of Veterans Affairs | 1 | 2011 | 557 | 0.070 |
Why?
| Social Workers | 2 | 2018 | 32 | 0.070 |
Why?
| Vascular Diseases | 1 | 2009 | 230 | 0.070 |
Why?
| Self Care | 1 | 2009 | 354 | 0.070 |
Why?
| Defibrillators, Implantable | 1 | 2010 | 286 | 0.070 |
Why?
| Blood Urea Nitrogen | 1 | 2006 | 51 | 0.070 |
Why?
| Biomarkers | 6 | 2015 | 3474 | 0.070 |
Why?
| Internal Medicine | 1 | 2008 | 211 | 0.070 |
Why?
| Coronary Artery Bypass | 2 | 2006 | 196 | 0.070 |
Why?
| National Health Programs | 1 | 2005 | 20 | 0.070 |
Why?
| Patient Admission | 4 | 2009 | 175 | 0.070 |
Why?
| Diet, Sodium-Restricted | 1 | 2006 | 32 | 0.070 |
Why?
| Dyspnea | 2 | 2018 | 224 | 0.060 |
Why?
| Body Temperature | 1 | 2006 | 211 | 0.060 |
Why?
| Fatigue | 2 | 2018 | 296 | 0.060 |
Why?
| Cost of Illness | 2 | 2004 | 257 | 0.060 |
Why?
| Self Report | 2 | 2022 | 700 | 0.060 |
Why?
| Patient Discharge | 4 | 2006 | 770 | 0.060 |
Why?
| Edema | 1 | 2006 | 119 | 0.060 |
Why?
| Patient Reported Outcome Measures | 2 | 2018 | 250 | 0.060 |
Why?
| Health Education | 1 | 2008 | 317 | 0.060 |
Why?
| Nurses | 2 | 2018 | 151 | 0.060 |
Why?
| Asthma | 1 | 2018 | 2150 | 0.060 |
Why?
| Natriuretic Peptide, Brain | 1 | 2005 | 99 | 0.060 |
Why?
| Interinstitutional Relations | 1 | 2005 | 55 | 0.060 |
Why?
| Hospital Costs | 1 | 2005 | 105 | 0.060 |
Why?
| Drug Costs | 1 | 2005 | 91 | 0.060 |
Why?
| Terminally Ill | 1 | 2005 | 33 | 0.060 |
Why?
| Specialization | 1 | 2005 | 117 | 0.060 |
Why?
| Cardiac Pacing, Artificial | 1 | 2005 | 80 | 0.060 |
Why?
| Coronary Care Units | 1 | 2004 | 13 | 0.060 |
Why?
| Counseling | 1 | 2007 | 346 | 0.060 |
Why?
| Nurse Practitioners | 1 | 2006 | 105 | 0.060 |
Why?
| Depressive Disorder | 1 | 2007 | 336 | 0.060 |
Why?
| United Kingdom | 1 | 2005 | 230 | 0.060 |
Why?
| Anemia | 1 | 2005 | 144 | 0.060 |
Why?
| Multicenter Studies as Topic | 1 | 2005 | 249 | 0.060 |
Why?
| Alcohol Drinking | 2 | 2009 | 653 | 0.060 |
Why?
| Nurse Administrators | 1 | 2004 | 35 | 0.060 |
Why?
| Educational Status | 1 | 2006 | 413 | 0.060 |
Why?
| Medicine | 1 | 2005 | 104 | 0.060 |
Why?
| Cultural Characteristics | 1 | 2004 | 58 | 0.060 |
Why?
| North America | 1 | 2004 | 263 | 0.060 |
Why?
| Internet | 1 | 2008 | 601 | 0.060 |
Why?
| Ibuprofen | 1 | 2003 | 73 | 0.060 |
Why?
| Vulnerable Populations | 1 | 2004 | 137 | 0.050 |
Why?
| Albuminuria | 1 | 2004 | 164 | 0.050 |
Why?
| Needs Assessment | 1 | 2005 | 320 | 0.050 |
Why?
| Thiazoles | 1 | 2003 | 110 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2003 | 115 | 0.050 |
Why?
| Weight Gain | 1 | 2006 | 454 | 0.050 |
Why?
| South Africa | 1 | 2023 | 162 | 0.050 |
Why?
| Health Behavior | 2 | 2011 | 704 | 0.050 |
Why?
| Continuity of Patient Care | 1 | 2005 | 255 | 0.050 |
Why?
| Bayes Theorem | 1 | 2004 | 333 | 0.050 |
Why?
| Risk Reduction Behavior | 1 | 2004 | 196 | 0.050 |
Why?
| Diuresis | 1 | 2002 | 8 | 0.050 |
Why?
| Cooperative Behavior | 1 | 2005 | 391 | 0.050 |
Why?
| Purinergic P1 Receptor Antagonists | 1 | 2002 | 7 | 0.050 |
Why?
| Ambulatory Care | 2 | 2006 | 479 | 0.050 |
Why?
| Hypertension, Malignant | 1 | 2002 | 2 | 0.050 |
Why?
| Furosemide | 1 | 2002 | 32 | 0.050 |
Why?
| Cardiac Tamponade | 1 | 2002 | 14 | 0.050 |
Why?
| Pain Measurement | 1 | 2004 | 449 | 0.050 |
Why?
| Total Quality Management | 1 | 2002 | 62 | 0.050 |
Why?
| Hospice Care | 1 | 2005 | 186 | 0.050 |
Why?
| Lupus Nephritis | 1 | 2002 | 52 | 0.050 |
Why?
| Health Care Costs | 1 | 2004 | 384 | 0.050 |
Why?
| Mortality | 2 | 2018 | 290 | 0.050 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 301 | 0.050 |
Why?
| Health Maintenance Organizations | 2 | 2012 | 96 | 0.050 |
Why?
| Algorithms | 1 | 2008 | 1494 | 0.050 |
Why?
| Blood Glucose | 2 | 2009 | 1826 | 0.040 |
Why?
| Veterans | 1 | 2011 | 1232 | 0.040 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2003 | 400 | 0.040 |
Why?
| Emergencies | 1 | 2021 | 150 | 0.040 |
Why?
| Contraindications | 3 | 2005 | 86 | 0.040 |
Why?
| Confidence Intervals | 2 | 2012 | 309 | 0.040 |
Why?
| Family Practice | 1 | 2004 | 428 | 0.040 |
Why?
| Length of Stay | 2 | 2017 | 960 | 0.040 |
Why?
| Coronary Disease | 1 | 2002 | 348 | 0.040 |
Why?
| Risk Adjustment | 1 | 2020 | 75 | 0.040 |
Why?
| Area Under Curve | 1 | 2020 | 277 | 0.040 |
Why?
| Sexuality | 1 | 2019 | 18 | 0.040 |
Why?
| Electric Countershock | 1 | 2019 | 104 | 0.040 |
Why?
| Research | 2 | 2018 | 398 | 0.040 |
Why?
| Geographic Mapping | 1 | 2018 | 21 | 0.040 |
Why?
| Hospitals | 1 | 2003 | 585 | 0.040 |
Why?
| Program Evaluation | 2 | 2018 | 841 | 0.040 |
Why?
| Alcoholism | 1 | 2004 | 715 | 0.040 |
Why?
| Zimbabwe | 1 | 2018 | 42 | 0.040 |
Why?
| Patient Health Questionnaire | 1 | 2018 | 20 | 0.040 |
Why?
| Palliative Medicine | 1 | 2018 | 14 | 0.040 |
Why?
| Anxiety | 2 | 2018 | 854 | 0.040 |
Why?
| Cholesterol, LDL | 2 | 2012 | 309 | 0.040 |
Why?
| Combined Modality Therapy | 2 | 2011 | 1127 | 0.040 |
Why?
| Capacity Building | 1 | 2018 | 51 | 0.040 |
Why?
| Time-to-Treatment | 1 | 2018 | 147 | 0.040 |
Why?
| Resuscitation | 1 | 2020 | 248 | 0.040 |
Why?
| Analysis of Variance | 1 | 2020 | 1227 | 0.040 |
Why?
| Sex Distribution | 1 | 2017 | 337 | 0.040 |
Why?
| Secondary Prevention | 1 | 2018 | 223 | 0.040 |
Why?
| Emotional Adjustment | 1 | 2016 | 18 | 0.040 |
Why?
| Peer Review | 2 | 2007 | 43 | 0.030 |
Why?
| Primary Prevention | 1 | 2018 | 170 | 0.030 |
Why?
| Sex Offenses | 1 | 2019 | 148 | 0.030 |
Why?
| Respiration, Artificial | 1 | 2020 | 525 | 0.030 |
Why?
| Feasibility Studies | 1 | 2019 | 750 | 0.030 |
Why?
| Diet Surveys | 1 | 2015 | 78 | 0.030 |
Why?
| Population Surveillance | 1 | 2018 | 395 | 0.030 |
Why?
| Motivation | 1 | 2020 | 496 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 87 | 0.030 |
Why?
| Insurance Coverage | 1 | 2017 | 204 | 0.030 |
Why?
| Neoplasms | 1 | 2009 | 2114 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2016 | 207 | 0.030 |
Why?
| Canada | 2 | 2006 | 337 | 0.030 |
Why?
| Emergency Medicine | 1 | 2018 | 239 | 0.030 |
Why?
| Medical Records | 2 | 2006 | 157 | 0.030 |
Why?
| Healthy Volunteers | 1 | 2015 | 191 | 0.030 |
Why?
| Language | 1 | 2017 | 257 | 0.030 |
Why?
| Consensus | 2 | 2007 | 531 | 0.030 |
Why?
| Mineralocorticoid Receptor Antagonists | 2 | 2005 | 43 | 0.030 |
Why?
| Administration, Oral | 2 | 2007 | 733 | 0.030 |
Why?
| Regression Analysis | 2 | 2009 | 960 | 0.030 |
Why?
| Pain Management | 1 | 2016 | 291 | 0.030 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2002 | 1115 | 0.030 |
Why?
| Aging | 1 | 2003 | 1635 | 0.030 |
Why?
| Stereotyped Behavior | 1 | 2012 | 19 | 0.030 |
Why?
| Up-Regulation | 1 | 2015 | 824 | 0.030 |
Why?
| Quality Indicators, Health Care | 2 | 2006 | 287 | 0.030 |
Why?
| Pain | 1 | 2018 | 712 | 0.030 |
Why?
| Disease Progression | 2 | 2011 | 2423 | 0.030 |
Why?
| Cardiac Resynchronization Therapy | 1 | 2012 | 42 | 0.020 |
Why?
| Culture | 1 | 2012 | 126 | 0.020 |
Why?
| Speech Recognition Software | 1 | 2010 | 11 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 2 | 2007 | 1871 | 0.020 |
Why?
| Cause of Death | 1 | 2012 | 368 | 0.020 |
Why?
| User-Computer Interface | 1 | 2010 | 146 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 61 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2018 | 1486 | 0.020 |
Why?
| Medication Therapy Management | 1 | 2010 | 67 | 0.020 |
Why?
| Hospitals, University | 1 | 2008 | 172 | 0.020 |
Why?
| Natriuresis | 1 | 2007 | 8 | 0.020 |
Why?
| Patient Participation | 1 | 2010 | 362 | 0.020 |
Why?
| Kidney Function Tests | 1 | 2007 | 141 | 0.020 |
Why?
| Ontario | 1 | 2006 | 108 | 0.020 |
Why?
| Risk | 1 | 2009 | 829 | 0.020 |
Why?
| Sleep Wake Disorders | 1 | 2009 | 233 | 0.020 |
Why?
| Pravastatin | 1 | 2006 | 28 | 0.020 |
Why?
| Lovastatin | 1 | 2006 | 27 | 0.020 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2006 | 47 | 0.020 |
Why?
| Heptanoic Acids | 1 | 2006 | 60 | 0.020 |
Why?
| Databases as Topic | 1 | 2005 | 63 | 0.020 |
Why?
| Hematocrit | 1 | 2005 | 86 | 0.020 |
Why?
| Family | 1 | 2009 | 597 | 0.020 |
Why?
| Cognition Disorders | 1 | 2009 | 475 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2007 | 724 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2005 | 103 | 0.020 |
Why?
| Hospitals, Urban | 1 | 2005 | 129 | 0.020 |
Why?
| Midwestern United States | 1 | 2004 | 39 | 0.020 |
Why?
| Northwestern United States | 1 | 2004 | 54 | 0.020 |
Why?
| Cognition | 1 | 2012 | 980 | 0.020 |
Why?
| Potassium | 1 | 2005 | 128 | 0.020 |
Why?
| Pyrroles | 1 | 2006 | 185 | 0.020 |
Why?
| Age Distribution | 1 | 2005 | 341 | 0.020 |
Why?
| Hospitals, Municipal | 1 | 2004 | 2 | 0.020 |
Why?
| Myocardial Revascularization | 1 | 2004 | 67 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2006 | 621 | 0.010 |
Why?
| Indoles | 1 | 2006 | 309 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1465 | 0.010 |
Why?
| Anti-Arrhythmia Agents | 1 | 2004 | 106 | 0.010 |
Why?
| Drug Utilization | 1 | 2004 | 167 | 0.010 |
Why?
| Drug Utilization Review | 1 | 2003 | 57 | 0.010 |
Why?
| Fee-for-Service Plans | 1 | 2003 | 79 | 0.010 |
Why?
| Arrhythmias, Cardiac | 1 | 2005 | 279 | 0.010 |
Why?
| Overweight | 1 | 2006 | 468 | 0.010 |
Why?
| Cardiotonic Agents | 1 | 2003 | 119 | 0.010 |
Why?
| Pyridines | 1 | 2006 | 425 | 0.010 |
Why?
| Drug Interactions | 1 | 2003 | 347 | 0.010 |
Why?
| Electrolytes | 1 | 2002 | 55 | 0.010 |
Why?
| Urinalysis | 1 | 2002 | 62 | 0.010 |
Why?
| Sodium | 1 | 2002 | 183 | 0.010 |
Why?
| Drug Combinations | 1 | 2002 | 289 | 0.010 |
Why?
| Diabetic Nephropathies | 1 | 2004 | 234 | 0.010 |
Why?
| Cardiac Catheterization | 1 | 2004 | 536 | 0.010 |
Why?
| Morbidity | 1 | 2002 | 278 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 2003 | 962 | 0.010 |
Why?
| Referral and Consultation | 1 | 2005 | 647 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2002 | 437 | 0.010 |
Why?
| Mental Disorders | 1 | 2008 | 903 | 0.010 |
Why?
| Heart Ventricles | 1 | 2005 | 713 | 0.010 |
Why?
| Substance-Related Disorders | 1 | 2008 | 951 | 0.010 |
Why?
| Recovery of Function | 1 | 2003 | 576 | 0.010 |
Why?
| Case-Control Studies | 1 | 2005 | 3054 | 0.010 |
Why?
| Hemodynamics | 1 | 2002 | 969 | 0.010 |
Why?
| Internship and Residency | 1 | 2004 | 957 | 0.010 |
Why?
|
|
Havranek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|